Advanced Biomed (ADVB) Accounts Payables (2024 - 2026)

Advanced Biomed has reported Accounts Payables for 3 years, with the latest figure at $1.4 million in Q1 2026.

• Quarterly Accounts Payables fell 64.6% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (down 64.6% YoY) and the FY2025 annual result came in at $1.9 million, down 29.76% from the prior year.
• Accounts Payables advanced to $1.4 million in Q1 2026 per ADVB's latest filing, from $1.2 million in the prior quarter.
• Over five years, Accounts Payables peaked at $4.0 million in Q1 2025 and troughed at $1.2 million in Q4 2025.
• A 3-year average of $2.5 million and a median of $2.7 million in 2024 frame the typical range for Accounts Payables.
• The widest YoY moves for Accounts Payables: up 29.76% in 2025, down 65.68% in 2025.
• Over 3 years, Accounts Payables stood at $3.6 million in 2024, then sank by 65.68% to $1.2 million in 2025, then advanced by 14.03% to $1.4 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $1.4 million, $1.2 million, and $3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.